Computational study prioritizes two benzohydrazide derivatives for EGFR testing
A computational and synthesis study prioritized benzohydrazide compounds 3d and 3f for experimental EGFR testing, while the lack of biological ...
A computational and synthesis study prioritized benzohydrazide compounds 3d and 3f for experimental EGFR testing, while the lack of biological ...
New MD Anderson studies report a first-in-class Werner helicase inhibitor, tile-based radiation that sharply improves brain metastasis survival, a negative ...
A phase Ib/II trial testing famitinib added to dalpiciclib and fulvestrant in HR-positive, HER2-negative advanced breast cancer met early response ...
A new study finds the experimental cancer drug zavondemstat and the research compound QC6352 act mainly by blocking the enzyme ...
A new study identifies the enzymes ADAM8 and ADAM17 as causally linked drivers of intrahepatic cholangiocarcinoma and demonstrates that a ...
In a groundbreaking development poised to redefine targeted cancer therapies, a team of researchers has identified a novel minor-groove DNA ...
In a landmark advancement for oncology, a collaborative research team from the Medical University of Vienna, the HUN-REN Research Centre ...
A revolutionary advancement in cancer treatment is on the horizon as scientists at King’s College London have developed a novel ...
In a groundbreaking development at the University of Bristol, chemists have unveiled a pioneering technique that fundamentally transforms the way ...
A groundbreaking advancement in glioblastoma treatment has emerged from The University of Texas Health Science Center at San Antonio (UT ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine